PT Industri Jamu dan Farmasi Sido Muncul Tbk's cash flow for dividends for the
three
months ended in Mar. 2026 was Rp0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was Rp0 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
PT Industri Jamu dan Farmasi Sido Muncul Tbk's annual payment of dividends
increased
from Dec. 2023 (Rp-1,068,000 Mil) to Dec. 2024 (Rp-1,080,000 Mil) and
increased
from Dec. 2024 (Rp-1,080,000 Mil) to Dec. 2025 (Rp-1,275,096 Mil).
PT Industri Jamu dan Farmasi Sido Muncul Tbk Cash Flow for Dividends Related Terms
PT Industri Jamu dan Farmasi Sido Muncul Tbk Cash Flow for Dividends Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Industri Jamu dan Farmasi Sido Muncul Tbk Cash Flow for Dividends Chart
PT Industri Jamu dan Farmasi Sido Muncul Tbk Annual Data
PT Industri Jamu dan Farmasi Sido Muncul Tbk Cash Flow for Dividends Calculation
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow for Dividends of Rp0 Mil mean?
PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) has a Cash Flow for Dividends of Rp0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for PT Industri Jamu dan Farmasi Sido Muncul Tbk and its competitors.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk's Cash Flow for Dividends too high?
PT Industri Jamu dan Farmasi Sido Muncul Tbk's current Cash Flow for Dividends is Rp0 Mil. Overall, PT Industri Jamu dan Farmasi Sido Muncul Tbk has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Industri Jamu dan Farmasi Sido Muncul Tbk's Cash Flow for Dividends compare to KHC and GIS?
PT Industri Jamu dan Farmasi Sido Muncul Tbk's Cash Flow for Dividends of Rp0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Consumer Packaged Goods company?
A good Cash Flow for Dividends depends on the Consumer Packaged Goods industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for PT Industri Jamu dan Farmasi Sido Muncul Tbk and its competitors. PT Industri Jamu dan Farmasi Sido Muncul Tbk's current Cash Flow for Dividends is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp605.75, compared to a current price of Rp368.00 — trading 39.2% below its estimated fair value. The current Cash Flow for Dividends is Rp0 Mil. PT Industri Jamu dan Farmasi Sido Muncul Tbk's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO), the current Cash Flow for Dividends is Rp0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Industri Jamu dan Farmasi Sido Muncul Tbk stock appears to be undervalued.
The current stock price of Rp368.00 is trading 39.2% below its estimated GF Value™ of Rp605.75.
GuruFocus considers PT Industri Jamu dan Farmasi Sido Muncul Tbk to be Significantly Undervalued.
Key valuation signals for ISX:SIDO:
Cash Flow for Dividends: Rp0 Mil
GF Value™: Rp605.75 vs. price of Rp368.00 (39.2% below fair value)
No single metric tells the full story. See the ISX:SIDO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Industri Jamu dan Farmasi Sido Muncul Tbk Business Description
PT Industri Jamu dan Farmasi Sido Muncul Tbk is focused on the herbal medicine and herbal products industry, with its products categorized into three distinct segments: Herbal Medicine and Supplements, Food and Beverages, and Pharmaceuticals. Its flagship herbal products include Tolak Angin, available in variants such as Tolak Angin Cair, Tolak Angin Cair Anak, Tolak Angin Sugar Free, Tolak Angin Batuk, and Tolak Angin Flu. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionery products. The Pharmacy segment sells pharmaceutical products, including Anacetine Syrup, Inflasone, Berlosid, Licokalk, and Licodexon. The majority of revenue is derived from the Herbal Medicine & Supplement segment.
80GF Score
Get the complete analysis for ISX:SIDO
Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SIDO has been successfully added to your 
